Covered recipient · General Payments record
MICHAEL AVERY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,076.51
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $448.09 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $219.18 | 16 |
| Amgen Inc. | $57.25 | 3 |
| Genentech USA, Inc. | $43.93 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.20 | 2 |
| Acerta Pharma LLC | $24.56 | 1 |
| Octapharma USA, Inc. | $24.34 | 1 |
| Janssen Biotech, Inc. | $22.57 | 1 |
| Sandoz Inc. | $19.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.39 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253517 | CMS |
| ABBVIE INC. | $7.86 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253519 | CMS |
| ABBVIE INC. | $20.39 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253521 | CMS |
| ABBVIE INC. | $14.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253523 | CMS |
| ABBVIE INC. | $28.53 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253525 | CMS |
| ABBVIE INC. | $9.67 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253527 | CMS |
| ABBVIE INC. | $15.51 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253529 | CMS |
| ABBVIE INC. | $5.80 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253531 | CMS |
| ABBVIE INC. | $13.98 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253533 | CMS |
| ABBVIE INC. | $13.14 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253535 | CMS |
| ABBVIE INC. | $18.52 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253537 | CMS |
| ABBVIE INC. | $7.98 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253539 | CMS |
| ABBVIE INC. | $6.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253541 | CMS |
| ABBVIE INC. | $5.78 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253543 | CMS |
| ABBVIE INC. | $17.74 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253545 | CMS |
| ABBVIE INC. | $14.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103253547 | CMS |
| Amgen Inc. | $21.86 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115432521 | CMS |
| Amgen Inc. | $19.66 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115432525 | CMS |
| Amgen Inc. | $15.73 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115432517 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105878847 | CMS |
| Genentech USA, Inc. | $22.30 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069012 | CMS |
| Genentech USA, Inc. | $21.63 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069016 | CMS |
| Janssen Biotech, Inc. | $22.57 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078837318 | CMS |
| Novartis Pharmaceuticals Corporation | $18.74 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086728871 | CMS |
| Novartis Pharmaceuticals Corporation | $18.46 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086728879 | CMS |
| Octapharma USA, Inc. | $24.34 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142312465 | CMS |
| Sandoz Inc. | $19.06 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089371276 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.